Indeed, the higher ratio of ADAR1 p110/p150 is not only significant in DLBCL versus FL or control B cells (Figure 1G) but is also associated with a late disease stage (Table S2). The gene discussed is ADAR; the disease is diffuse large B-cell lymphoma.